کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
3999071 | 1601774 | 2009 | 12 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Li-Fraumeni Syndrome: The Genetics and Treatment Considerations for the Sarcoma and Associated Neoplasms
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
تومور شناسی
پیش نمایش صفحه اول مقاله
![عکس صفحه اول مقاله: Li-Fraumeni Syndrome: The Genetics and Treatment Considerations for the Sarcoma and Associated Neoplasms Li-Fraumeni Syndrome: The Genetics and Treatment Considerations for the Sarcoma and Associated Neoplasms](/preview/png/3999071.png)
چکیده انگلیسی
Li-Fraumeni syndrome is an autosomal dominant disorder first reported by Drs Li and Fraumeni in 1969. Malkin was the first to describe a germline mutation as an underlying defect of Li-Fraumeni syndrome. Cancer risk in mutation carriers has been estimated to be 50% by age 40 and 90% by age 60. Children of affected parents have an approximate 50% risk of inheriting the familial mutation. Functional assays have been established that allow for easy genetic testing for TP53 mutation. Treatment goals center on early detection and surgical resection of affected organ. Targeted therapy for the TP53 gene may hold promise for the future.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Surgical Oncology Clinics of North America - Volume 18, Issue 1, January 2009, Pages 145-156
Journal: Surgical Oncology Clinics of North America - Volume 18, Issue 1, January 2009, Pages 145-156
نویسندگان
Brandi MD, Quyen MD, Benjamin D.L. MD, FACS,